Related Experiment Video
Updated: May 28, 2026

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
An Observational Study of Human Umbilical Cord Tissue Allografts for Paraspinal Muscle and Entheses Defects in the
Conrad Tamea1, Jeff Buchalter2, Jason Capra2
1Orthopedic Associates of Tampa Bay, 4505 N Armenia Ave #101, Tampa, FL 33603, USA.
Insights
Human umbilical cord tissue allografts (UCTAs) show preliminary effectiveness in reducing pain and improving function for patients with paraspinal muscle degeneration. Further research is needed to confirm findings and optimize treatment protocols.
Area of Science:
- Regenerative Medicine
- Orthopedics
- Biomaterials
Background:
- Paraspinal muscle degeneration, often linked to aging and injury, leads to connective tissue damage and lower back pain (LBP).
- Human umbilical cord tissue allografts (UCTAs) offer a collagen-rich matrix that can potentially replace degenerated connective tissue.
Purpose of the Study:
- To analyze preliminary findings on the use of UCTAs for supplementing degenerated thoracic and lumbar paraspinal muscles.
- To evaluate UCTAs in patients refractory to standard conservative treatments for LBP.
Main Methods:
- An observational repository study included 117 patients with paraspinal muscle degeneration.
- Patients received one to three UCTA applications.
- Outcomes were assessed using the Numeric Pain Rating Scale (NPRS), WOMAC, and Quality-of-Life Scale (QOLS).
Main Results:
- All patient groups demonstrated improvements in NPRS and WOMAC scores.
- Multiple UCTA applications showed statistically significant improvements.
- No adverse events or complications were reported during the study.
Conclusions:
- This pilot study suggests UCTAs may be effective for paraspinal muscle degeneration and LBP.
- Further randomized controlled trials are necessary to validate efficacy and establish optimal dosage.
- Comparative studies against other conservative interventions are recommended.
Abstract:
Introduction: With age and injury, the infiltration of fat in the paraspinal muscles can cause degeneration, disorganizing the structural integrity of the connective tissue and causing lower back pain (LBP). Human umbilical cord tissue allografts (UCTAs) have a collagen-rich matrix with various extracellular matrix (ECM) components that can replace damaged connective tissue. The objective of this paper is to analyze the preliminary findings from an observational repository on UCTAs for the supplementation of degenerated tissue in thoracic and lumbar paraspinal muscles refractory to standard conservative methods through patient-reported scales. Materials and Methods: A total of 117 patients from an observational repository were identified with paraspinal muscle degeneration. Patients received one to three applications of UCTAs; outcomes were tracked using the Numeric Pain Rating Scale (NPRS), the Western Ontario and McMaster University Arthritis Index (WOMAC), and the Quality-of-Life Scale (QOLS). Results: All groups showed positive improvement in the NPRS and WOMAC scales. Multi-application groups revealed statistically significant differences in the analyses. No adverse events or complications were reported. Discussion: Limitations included a lack of a control group, non-standardized application protocol, and the increase in recall and response bias due to using patient-reported measures. Conclusions: This pilot investigation presents the preliminary effectiveness necessary in hypothesis generation for continued research through randomized controlled trials to validate efficacy, establish optimal dosage protocols, and compare UCTAs to other conservative interventions.

